Maya Boudiffa

Maya Boudiffa

Auto-generated profile, based on publicly available information

Maya Boudiffa

Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2008 in Journal of Experimental Medicine
Verified
Journal Article
Open access
LMLuc Malaval
Luc Malaval
NWNdéyé Marième Wade-Guéye
Ndéyé Marième Wade-Guéye
MBMaya Boudiffa
Maya Boudiffa
JFJia Fei
Jia Fei
RZRalph Zirngibl
Ralph Zirngibl
JAJane E. Aubin
Jane E. Aubin
Bone sialoprotein (BSP) and osteopontin (OPN) are both highly expressed in bone, but their functional specificities are unknown. OPN knockout (−/−) mice do not lose bone in a model of hindlimb disuse (tail suspension), showing the importance of OPN in bone remodeling. We report that BSP−/− mice are viable and breed normally, but their weight and size are lower than wild-type (WT) mice. Bone is undermineralized in fetuses and young adults, but not in older (≥12 mo) BSP−/− mice. At 4 mo, BSP−/− mice display thinner cortical bones than WT, but greater trabecular bone volume with very low bone formation rate, which indicates reduced resorption, as confirmed by lower osteoclast surfaces. Although the frequency of total colonies and committed osteoblast colonies is the same, fewer mineralized colonies expressing decreased levels of osteoblast markers form in BSP−/− versus WT bone marrow stromal cultures. BSP−/− hematopoietic progenitors form fewer osteoclasts, but their resorptive activity on dentin is normal. Tail-suspended BSP−/− mice lose bone in hindlimbs, as expected. In conclusion, BSP deficiency impairs bone growth and mineralization, concomitant with dramatically reduced bone formation. It does not, however, prevent the bone loss resulting from loss of mechanical stimulation, a phenotype that is clearly different from OPN−/− mice.

14 December 2015 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
MDMichal Dudek
Michal Dudek
NGNicole Gossan
Nicole Gossan
NYNan Yang
Nan Yang
HIHee-Jeong Im
Hee-Jeong Im
JRJayalath P.D. Ruckshanthi
Jayalath P.D. Ruckshanthi
QMQing-Jun Meng
Qing-Jun Meng
Osteoarthritis (OA) is the most prevalent and debilitating joint disease, and there are currently no effective disease-modifying treatments available. Multiple risk factors for OA, such as aging, result in progressive damage and loss of articular cartilage. Autonomous circadian clocks have been identified in mouse cartilage, and environmental disruption of circadian rhythms in mice predisposes animals to OA-like damage. However, the contribution of the cartilage clock mechanisms to the maintenance of tissue homeostasis is still unclear. Here, we have shown that expression of the core clock transcription factor BMAL1 is disrupted in human OA cartilage and in aged mouse cartilage. Furthermore, targeted Bmal1 ablation in mouse chondrocytes abolished their circadian rhythm and caused progressive degeneration of articular cartilage. We determined that BMAL1 directs the circadian expression of many genes implicated in cartilage homeostasis, including those involved in catabolic, anabolic, and apoptotic pathways. Loss of BMAL1 reduced the levels of phosphorylated SMAD2/3 (p-SMAD2/3) and NFATC2 and decreased expression of the major matrix-related genes Sox9, Acan, and Col2a1, but increased p-SMAD1/5 levels. Together, these results define a regulatory mechanism that links chondrocyte BMAL1 to the maintenance and repair of cartilage and suggest that circadian rhythm disruption is a risk factor for joint diseases such as OA.

1 October 2011 in Cell Metabolism
Verified
Journal Article
Closed access
MFMathieu Ferron
Mathieu Ferron
MBMaya Boudiffa
Maya Boudiffa
MAMichel Arsenault
Michel Arsenault
MRMohamed Rached
Mohamed Rached
MPMonica Pata
Monica Pata
JVJean Vacher
Jean Vacher

9 May 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
WBWafa Bouleftour
Wafa Bouleftour
MBMaya Boudiffa
Maya Boudiffa
NWNdeye Marième Wade-Gueye
Ndeye Marième Wade-Gueye
GBGuénaëlle Bouët
Guénaëlle Bouët
MCMarco Cardelli
Marco Cardelli
LMLuc Malaval
Luc Malaval
Adult Ibsp-knockout mice (BSP−/−) display shorter stature, lower bone turnover and higher trabecular bone mass than wild type, the latter resulting from impaired bone resorption. Unexpectedly, BSP knockout also affects reproductive behavior, as female mice do not construct a proper "nest" for their offsprings. Multiple crossing experiments nonetheless indicated that the shorter stature and lower weight of BSP−/− mice, since birth and throughout life, as well as their shorter femur and tibia bones are independent of the genotype of the mothers, and thus reflect genetic inheritance. In BSP−/− newborns, µCT analysis revealed a delay in membranous primary ossification, with wider cranial sutures, as well as thinner femoral cortical bone and lower tissue mineral density, reflected in lower expression of bone formation markers. However, trabecular bone volume and osteoclast parameters of long bones do not differ between genotypes. Three weeks after birth, osteoclast number and surface drop in the mutants, concomitant with trabecular bone accumulation. The growth plates present a thinner hypertrophic zone in newborns with lower whole bone expression of IGF-1 and higher IHH in 6 days old BSP−/− mice. At 3 weeks the proliferating zone is thinner and the hypertrophic zone thicker in BSP−/− than in BSP+/+ mice of either sex, maybe reflecting a combination of lower chondrocyte proliferation and impaired cartilage resorption. Six days old BSP−/− mice display lower osteoblast marker expression but higher MEPE and higher osteopontin(Opn)/Runx2 ratio. Serum Opn is higher in mutants at day 6 and in adults. Thus, lack of BSP alters long bone growth and membranous/cortical primary bone formation and mineralization. Endochondral development is however normal in mutant mice and the accumulation of trabecular bone observed in adults develops progressively in the weeks following birth. Compensatory high Opn may allow normal endochondral development in BSP−/− mice, while impairing primary mineralization.

1 December 2016 in Mechanisms of Ageing and Development
Verified
Journal Article
Open access
Enrico Dall'AraEnrico Dall'Ara
Enrico Dall'Ara
MBM. Boudiffa
M. Boudiffa
CTC. Taylor
C. Taylor
DSDavid Schug
David Schug
EFE. Fiegle
E. Fiegle
RMRalph Müller
Ralph Müller
Several non-invasive imaging techniques are used to investigate the effect of pathologies and treatments over time in mouse models. Each preclinical in vivo technique provides longitudinal and quantitative measurements of changes in tissues and organs, which are fundamental for the evaluation of alterations in phenotype due to pathologies, interventions and treatments. However, it is still unclear how these imaging modalities can be used to study ageing with mice models. Almost all age related pathologies in mice such as osteoporosis, arthritis, diabetes, cancer, thrombi, dementia, to name a few, can be imaged in vivo by at least one longitudinal imaging modality. These measurements are the basis for quantification of treatment effects in the development phase of a novel treatment prior to its clinical testing. Furthermore, the non-invasive nature of such investigations allows the assessment of different tissue and organ phenotypes in the same animal and over time, providing the opportunity to study the dysfunction of multiple tissues associated with the ageing process. This review paper aims to provide an overview of the applications of the most commonly used in vivo imaging modalities used in mouse studies: micro-computed-tomography, preclinical magnetic-resonance-imaging, preclinical positron-emission-tomography, preclinical single photon emission computed tomography, ultrasound, intravital microscopy, and whole body optical imaging.

1 September 2010 in Journal of Bone and Mineral Research
Verified
Journal Article
Open access
PDF file
MBMaya Boudiffa
Maya Boudiffa
NWNdéye Marième Wade-Gueye
Ndéye Marième Wade-Gueye
AGAlain Guignandon
Alain Guignandon
AVArnaud Vanden-Bossche
Arnaud Vanden-Bossche
OSOdile Sabido
Odile Sabido
LMLuc Malaval
Luc Malaval
Bone sialoprotein (BSP) and osteopontin (OPN) belong to the small integrin‐binding ligand N‐linked glycoprotein (SIBLING) family, whose members interact with bone cells and bone mineral. Previously, we showed that BSP knockout (BSP−/−) mice have a higher bone mass than wild type (BSP+/+) littermates, with very low bone‐formation activity and reduced osteoclast surfaces and numbers. Here we report that approximately twofold fewer tartrate‐resistant acid phosphatase (TRACP)–positive cells and approximately fourfold fewer osteoclasts form in BSP−/− compared with BSP+/+ spleen cell cultures. BSP−/− preosteoclast cultures display impaired proliferation and enhanced apoptosis. Addition of RGD‐containing proteins restores osteoclast number in BSP−/− cultures to BSP+/+ levels. The expression of osteoclast‐associated genes is markedly altered in BSP−/− osteoclasts, with reduced expression of cell adhesion and migration genes (αV integrin chain and OPN) and increased expression of resorptive enzymes (TRACP and cathepsin K). The migration of preosteoclasts and mature osteoclasts is impaired in the absence of BSP, but resorption pit assays on dentine slices show no significant difference in pit numbers between BSP+/+ and BSP−/− osteoclasts. However, resorption of mineral‐coated slides by BSP−/− osteoclasts is markedly impaired but is fully restored by coating the mineral substrate with hrBSP and partly restored by hrOPN coating. In conclusion, lack of BSP affects both osteoclast formation and activity, which is in accordance with in vivo findings. Our results also suggest at least some functional redundancy between BSP and OPN that remains to be clarified. © 2010 American Society for Bone and Mineral Research.